Renishaw wins FDA approval for neurosurgery planning software

This article was originally published here
Share

renishawRenishaw, a British engineering company, received approval by federal officials to sell the latest version of its neurosurgery planning software in the U.S.

The FDA granted 510(k) clearance for Renishaw’s neuroinspire software that blends MRI and CT datasets into a 3D volume, enabling neurosurgeons to identify and outline regions of interest. The approach is designed to minimize the chance of hitting key anatomy during the procedure.

Get the full story at our sister site, The Robot Report.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply